First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone
Synthetic cannabinoids- (SCs-) induced psychosis is a growing public health concern. It leads to significant impairment, including emotional distress, difficulty communicating, and other debilitating symptoms. In this case report, we discuss a patient with no previous history of psychotic symptoms,...
Saved in:
| Main Authors: | Aaron J. Roberto, Aileen Lorenzo, Kevin J. Li, Jonathan Young, Abhishek Mohan, Subhash Pinnaka, Kyle A. B. Lapidus |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Case Reports in Psychiatry |
| Online Access: | http://dx.doi.org/10.1155/2016/7257489 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Primary care approach to first-episode psychosis
by: Tabitha Jia Ling Mok, et al.
Published: (2024-10-01) -
EMCDDA Framework for Naming Synthetic Cannabinoids
by: B. Pulver, et al.
Published: (2024-12-01) -
Corrigendum: Primary care approach to first-episode psychosis
Published: (2024-12-01) -
The Wide and Unpredictable Scope of Synthetic Cannabinoids Toxicity
by: Jose Orsini, et al.
Published: (2015-01-01) -
Intervention Programmes for First-Episode Psychosis: A Scoping Review
by: Marta Gouveia, et al.
Published: (2025-01-01)